XML 25 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. Segment Information and Concentrations (Details) (USD $)
3 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Depreciation and Amortization     $ 89,000 $ 99,300
Benchtop Laboratory Equipment [Member]
       
Net Sales 1,164,900 1,108,500 2,229,700 2,183,600
Foreign Sales 747,900 755,100 1,369,600 1,363,700
Profit (Loss) 157,200 100,200 274,800 260,600
Assets 2,485,700 2,467,600 2,485,700 2,467,600
Long-lived Asset Expenditures 7,100 4,500 9,200 14,000
Depreciation and Amortization 11,500 12,300 22,600 24,300
Catalyst Research Instruments [Member]
       
Net Sales 664,900 89,100 949,200 554,900
Foreign Sales 279,800 8,400 519,000 121,100
Profit (Loss) 68,200 (117,800) (66,100) (176,400)
Assets 1,695,400 1,375,700 1,695,400 1,375,700
Long-lived Asset Expenditures 700 2,800 18,100 49,500
Depreciation and Amortization 9,200 27,800 18,500 63,000
Bioprocessing Systems [Member]
       
Net Sales 47,100    49,700   
Foreign Sales            
Profit (Loss) (30,900) (32,300) (105,900) (32,300)
Assets 963,100 866,600 963,100 866,600
Long-lived Asset Expenditures    876,000    876,000
Depreciation and Amortization 24,000 12,000 47,900 12,000
Corporate and Other [Member]
       
Net Sales            
Foreign Sales            
Profit (Loss)    (33,600)    (58,200)
Assets 915,800 1,481,800 915,800 1,481,800
Long-lived Asset Expenditures            
Depreciation and Amortization            
Consolidated [Member]
       
Net Sales 1,876,900 1,197,600 3,228,600 2,738,500
Foreign Sales 1,027,700 763,500 1,888,600 1,484,800
Profit (Loss) 194,500 (83,500) 102,800 (6,300)
Assets 6,060,000 6,191,700 6,060,000 6,191,700
Long-lived Asset Expenditures 7,800 883,300 27,300 939,500
Depreciation and Amortization $ 44,700 $ 52,100 $ 89,000 $ 99,300